Alcohol
Volume 33, Issue 1 , Pages 51-61 , May 2004

Effects of chronic naltrexone treatment in rats on place preference and locomotor activation after acute administration of cocaethylene or ethanol plus cocaine

  • Helen J.K. Sable

      Affiliations

    • Corresponding Author InformationCorresponding author and present address: Indiana University School of Medicine, The Institute of Psychiatric Research, 791 Union Drive, Room M116, Indianapolis, IN 46202, USA. Tel.: +1-317-278-4812; fax: +1-317-274-1365.
    • ,
  • Sasha L. White
    • ,
  • Rhea E. Steinpreis

Received 22 October 2003 ,Revised 8 April 2004 ,Accepted 20 April 2004.

References 

  1. Bell RL, Rodd-Henricks ZA, Webster AA, Lumeng L, Li T-K, McBride WJ, et al. Heart rate and motor-activating effects of orally self-administered ethanol in alcohol-preferring (P) rats. Alcohol Clin Exp Res. 2002;26:1162–1170
  2. Beyer CE, Steketee JD. Cocaine sensitization: modulation by dopamine D2 receptors. Cereb Cortex. 2002;12:526–535
  3. Bienkowski P, Kostowski W, Koros E. Ethanol-reinforced behaviour in the rat: effects of naltrexone. Eur J Pharmacol. 1999;374:321–327
  4. Bienkowski P, Kuca P, Piasecki J, Kostowski W. Low dose of ethanol induces conditioned place preference in rats after repeated exposures to ethanol or saline injections. Alcohol Alcohol. 1996;31:547–553
  5. Bilsky EJ, Montegut MJ, Delong CL, Reid LD. Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 1992;50:PL85–PL90
  6. Bormann NM, Cunningham CL. Ethanol-induced conditioned place aversion in rats: effect of interstimulus interval. Pharmacol Biochem Behav. 1998;59:427–432
  7. Bozarth MA. Evidence for the rewarding effects of ethanol using the conditioned place preference method. Pharmacol Biochem Behav. 1990;35:485–487
  8. Bradberry CW, Lee T, Jatlow P. Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence. Psychopharmacology (Berl). 1999;146:87–92
  9. Bradberry CW, Nobiletti JB, Elsworth JD, Murphy B, Jatlow P, Roth RH. Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem. 1993;60:1429–1435
  10. Brown EE, Finlay JM, Wong JTF, Damsma G, Fibiger HC. Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther. 1991;256:119–126
  11. Chester JA, Risinger FO, Cunningham CL. Ethanol reward and aversion in mice bred for sensitivity to ethanol withdrawal. Alcohol Clin Exp Res. 1998;22:468–473
  12. Collins SL, Izenwasser S. Cocaine differentially alters behavior and neurochemistry in periadolescent versus adult rats. Brain Res Dev Brain Res. 2002;138:27–34
  13. Colombo G, Agabio R, Lobina C, Reali R, Vacca G, Gessa GL. Stimulation of locomotor activity by voluntarily consumed ethanol in Sardinian alcohol-preferring rats. Eur J Pharmacol. 1998;357:109–113
  14. Coonfield DL, Hill KG, Kaczmarek HJ, Ferraro FM, Kiefer SW. Low doses of naltrexone reduce palatability and consumption of ethanol in outbred rats. Alcohol. 2002;26:43–47
  15. Corrigall WA, Coen KM. Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology (Berl). 1991;104:167–170
  16. Cunningham CL. Flavor and location aversions produced by ethanol. Behav Neural Biol. 1979;27:362–367
  17. Cunningham CL. Spatial aversion conditioning with ethanol. Pharmacol Biochem Behav. 1981;14:263–264
  18. Cunningham CL, Clemans JM, Fidler TL. Injection timing determines whether intragastric ethanol produces conditioned place preference or aversion in mice. Pharmacol Biochem Behav. 2002;72:659–668
  19. Cunningham CL, Henderson CM. Ethanol-induced conditioned place aversion in mice. Behav Pharmacol. 2000;11:591–602
  20. Cunningham CL, Okorn DM, Howard CE. Interstimulus interval determines whether ethanol produces conditioned place preference or aversion in mice. Anim Learn Behav. 1997;25:32–42
  21. Cunningham CL, Tull LE, Rindal KE, Meyer PJ. Distal and proximal pre-exposure to ethanol in the place conditioning task: tolerance to aversive effect, sensitization to activating effect, but no change in rewarding effect. Psychopharmacology (Berl). 2002;160:414–424
  22. Davidson D, Amit Z. Naltrexone blocks acquisition of voluntary ethanol intake in rats. Alcohol Clin Exp Res. 1997;21:677–683
  23. Davidson D, Palfai T, Bird C, Swift R. Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcohol Clin Exp Res. 1999;23:195–203
  24. Devine DP, Leone P, Pocock D, Wise RA. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther. 1993;266:1236–1246
  25. Di Chiara G. Psychobiology of the role of dopamine in drug-abuse and addiction. Neurosci Res Commun. 1995;17:133–143
  26. Doty P, de Wit H. Effects of naltrexone pretreatment on the subjective and performance effects of ethanol in social drinkers. Behav Pharmacol. 1995;6:386–394
  27. Elliott PJ, Rosen GM, Nemeroff CB. A comparison of cocaine and its metabolite norcocaine: effects on locomotor activity. Pharmacol Biochem Behav. 1987;26:573–575
  28. Ferraro FM, Hill KG, Coonfield DL, Sampson A, Hickel B, Kiefer SW. Continuous naltrexone administration decreases consumption of 10% alcohol in male rats. Abstr Soc Neurosci. 2002;26:1039
  29. Fish EW, DeBold JF, Miczek KA. Repeated alcohol: behavioral sensitization and alcohol-heightened aggression in mice. Psychopharmacology (Berl). 2002;160:39–48
  30. Frye GD, Breese GR. An evaluation of the locomotor stimulating action of ethanol in rats and mice. Psychopharmacology (Berl). 1981;75:372–379
  31. Gauvin DV, Briscoe RJ, Baird TJ, Vallett M, Carl KL, Holloway FA. Physiological and subjective effects of acute cocaine withdrawal (crash) in rats. Pharmacol Biochem Behav. 1997;57:923–934
  32. Gauvin DV, Holloway FA. Historical factors in the development of ETOH-conditioned place preference. Alcohol. 1992;9:1–7
  33. Goodwin FLW, Campisi M, Babinska I, Amit Z. Effects of naltrexone on the intake of ethanol and flavored solutions in rats. Alcohol. 2001;25:9–19
  34. Grahame NJ, Chester JA, Rodd-Henricks K, Li T-K, Lumeng L. Alcohol place preference conditioning in high- and low-alcohol preferring selected lines of mice. Pharmacol Biochem Behav. 2001;68:805–814
  35. Grahame NJ, Rodd-Henricks K, Li T-K, Lumeng L. Ethanol locomotor sensitization, but not tolerance correlates with selection for alcohol preference in high- and low-alcohol preferring mice. Psychopharmacology (Berl). 2000;151:252–260
  36. Grant BF, Harford TC. Concurrent and simultaneous use of alcohol with cocaine: results of a national survey. Drug Alcohol Depend. 1990;25:97–104
  37. Hearn WL, Flynn DD, Hime GW, Rose S, Cofino JC, Mantero-Atienza E, et al. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem. 1991;56:698–701
  38. Hersh D, Van Kirk JR, Kranzler HR. Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology (Berl). 1998;139:44–52
  39. Hill KG, Kiefer SW. Naltrexone treatment increases the aversiveness of alcohol for outbred rats. Alcohol Clin Exp Res. 1997;21:637–641
  40. Horowitz JM, Kristal MB, Torres G. Differential behavioral responses to cocaethylene of Long–Evans and Sprague–Dawley rats: role of serotonin. Synapse. 1997;26:11–21
  41. Hyytiä P, Ingman K, Soini SL, Laitinen JT, Korpi ER. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking. Naunyn Schmiedebergs Arch Pharmacol. 1999;360:391–401
  42. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council . Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996;
  43. Itzhak Y, Martin JL. Effects of cocaine, nicotine, dizocilpine and alcohol on mice locomotor activity: cocaine–alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites. Brain Res. 1999;818:204–211
  44. Jackson HC, Nutt DJ. A single preexposure produces sensitization to the locomotor effects of cocaine in mice. Pharmacol Biochem Behav. 1993;45:733–735
  45. Jatlow P, Elsworth JD, Bradberry CW, Winger G, Taylor JR, Russell R, et al. Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine–ethanol ingestion. Life Sci. 1991;48:1787–1794
  46. Katz JL, Terry P, Witkin JM. Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethyl-ester (cocaethylene). Life Sci. 1992;50:1351–1361
  47. Kosten TA, Marby DW, Nestler EJ. Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment. Life Sci. 1991;49:PL201–PL206
  48. Landry MJ. An overview of cocaethylene, an alcohol-derived, psychoactive, cocaine metabolite. J Psychoactive Drugs. 1992;24:273–276
  49. Longo LP, Bohn MJ. Alcoholism pharmacotherapy: new approaches to an old disease. Hosp Physician. 2001;37:33–43
  50. Masur J, Oliveira de Souza ML, Zwicker AP. The excitatory effect of ethanol: absence in rats, no tolerance and increased sensitivity in mice. Pharmacol Biochem Behav. 1986;24:1225–1228
  51. McCaul ME, Wand GS, Eissenberg T, Rohde CA, Cheskin LJ. Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology. 2000;22:480–492
  52. Menkens K, Bilsky EJ, Wild KD, Portoghese PS, Reid LD, Porreca F. Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole. Eur J Pharmacol. 1992;219:345–346
  53. Middaugh LD, Bandy A-LE. Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice. Psychopharmacology (Berl). 2000;151:321–327
  54. Milton GV, Randall PK, Erickson CK. Low-dose effect of ethanol on locomotor activity induced by activation of the mesolimbic system. Alcohol Clin Exp Res. 1995;19:768–776
  55. Mitchem LD, Kruschel CK, Dallman E, Anders KA, Czapiga M, Panos JJ, et al. The effects of the naltrexone implant on rodent social interactions and cocaine-induced conditioned place preference. Pharmacol Biochem Behav. 1999;62:97–102
  56. Myers RD, Lankford MF. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone. Neuropsychopharmacology. 1996;14:139–149
  57. Neisewander JL, Pierce RC, Bardo MT. Naloxone enhances the expression of morphine-induced conditioned place preference. Psychopharmacology (Berl). 1990;100:201–205
  58. Paivarinta P, Korpi ER. Voluntary ethanol drinking increases locomotor activity in alcohol-preferring AA rats. Pharmacol Biochem Behav. 1993;44:127–132
  59. Pan W-J, Hedaya MA. Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects. J Pharm Sci. 1999;88:468–474
  60. Prinssen EP, Kleven MS, Koek W. Repeated administration of cocaethylene induces context-dependent sensitization to its locomotor effects. Psychopharmacology (Berl). 1996;124:300–305
  61. Przegalinski E, Filip M, Papla I, Czepiel K. Effects of 5-HT1B receptor ligands microinjected into the accumbal shell or core on the cocaine-induced locomotor hyperactivity in rats. J Physiol Pharmacol. 2002;53:383–394
  62. Ramsey NF, van Ree JM. Chronic pretreatment with naltrexone facilitates acquisition of intravenous cocaine self-administration in rats. Eur Neuropsychopharmacol. 1990;1:55–61
  63. Reid LD, Hunter GA, Beaman CM, Hubbell CL. Toward understanding ethanol's capacity to be reinforcing: a conditioned place preference following injections of ethanol. Pharmacol Biochem Behav. 1985;22:483–487
  64. Rush CR, Ali JA. Naltrexone does not attenuate the acute behavioral effects of ethanol or pentobarbital in humans. Behav Pharmacol. 1999;10:401–413
  65. Sala M, Braida D, Colombo M, Groppetti A, Sacco S, Gori E, et al. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J Pharmacol Exp Ther. 1995;274:450–457
  66. Schechter MD. Cocaethylene produces conditioned place preference in rats. Pharmacol Biochem Behav. 1995;51:549–552
  67. Schechter MD, Calcagnetti DJ. Trends in place preference conditioning with a cross-indexed bibliography; 1957–1991. Neurosci Biobehav Rev. 1993;17:21–41
  68. Shippenberg TS, Bals-Kubik R, Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther. 1993;265:53–59
  69. Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A. 1992;89:2046–2050
  70. Stewart RB, Murphy JM, McBride WJ, Lumeng L, Li T-K. Place conditioning with alcohol in alcohol-preferring and -nonpreferring rats. Pharmacol Biochem Behav. 1996;53:487–491
  71. Stromberg MF, Casale M, Volpicelli L, Volpicelli JR, O'Brien CP. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and β-funaltrexamine on ethanol consumption in the rat. Alcohol. 1998;15:281–289
  72. Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP. Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol. 2001;23:109–116
  73. Stromberg MF, Volpicelli JR, O'Brien CP. Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat. Alcohol Clin Exp Res. 1998;22:2186–2191
  74. Torres G, Horowitz JM, Lee S, Rivier C. Cocaethylene stimulates the secretion of ACTH and corticosterone and the transcriptional activation of hypothalamic NGFI-B. Brain Res Mol Brain Res. 1996;31:225–232
  75. Uhl GR, Hall FS, Sora I. Cocaine, reward, movement and monoamine transporters. Mol Psychiatry. 2002;7:21–26
  76. Unterwald EM, Anton B, To T, Lam H, Evans CJ. Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone. Neuroscience. 1998;85:897–905
  77. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876–880
  78. Waller MB, Murphy JM, McBride WJ, Lumeng L, Li T-K. Effect of low dose ethanol on spontaneous motor activity in alcohol-preferring and -nonpreferring lines of rats. Pharmacol Biochem Behav. 1986;24:617–623
  79. Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther. 1996;279:524–538
  80. Wang PJ, Stromberg M, Replenski S, Snyder-Mackler A, Mackler SA. The relationship between cocaine-induced increases in NACl and behavioral sensitization. Pharmacol Biochem Behav. 2003;75:49–54
  81. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94:469–492
  82. Yoburn BC, Cohen AH, Inturrisi CE. Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat. J Pharmacol Exp Ther. 1986;237:126–130

PII: S0741-8329(04)00080-1

doi: 10.1016/j.alcohol.2004.04.004

Alcohol
Volume 33, Issue 1 , Pages 51-61 , May 2004

Article Tools

* Image Usage & Resolution